Health Care: Drugs

Medivation Inc (MDVN: NASDAQ)

$81.42 n/a | n/a%
09/26/16 - 04:00 PM ET
Company Profile
Price and Volume
Recent Price 81.42
52 Week High 81.45
52 Week Low 26.41
Avg. Daily Vol. (Mil) 4.25
Beta (3 year) 1.26
Share Related Items
Mkt Cap (Mil) 13,509.91
Shares Out (Mil) 165.93
Float (Mil) 141.75
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 4.00
Current Ratio 4.20
LT Debt/ Equity 0.02
Total Debt / Equity 0.02
Valuation Ratios
Price Earnings 54.10
Price/Sales 13.56
Price/Book 15.01
Price/Cash Flow 51.20
Per Share Data
Earnings 1.51
Sales 6.01
Book Value 5.43
Cash Flow 1.59
Business Summary
Medivation Inc is a biopharmaceutical company engaged in the development of novel small molecule drugs to treat diseases like Alzheimer's disease and Huntington disease.
General Information
36th Floor, 525 Market Stree
San Francisco, CA 94105
Industry : Drugs
Sector: Health Care
Employees: 628
CEO: Dr. David T. Hung,M.D.
Short Interest
Current Month (Mil) 3.24
Previous Month (Mil) 2.46
Short Interest Ratio (Days) 0.50
Management Effectiveness
Return on Equity 28.10
Return on Assets 19.10
Return on Investments 27.50
Gross Margin n.a.
EBIT Margin 39.90
Profit Margin 25.40

Portfolios with MDVN

Latest MDVN Headlines from TheStreet

More Financial News for MDVN

Press Releases for MDVN

See All Press Releases

Partner Headlines for MDVN

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter